Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulder, H.
Right arrow Articles by Ahrén, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulder, H.
Right arrow Articles by Ahrén, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:122-128, 2004
© 2004 by the American Diabetes Association, Inc.

Inhibition of Lipase Activity and Lipolysis in Rat Islets Reduces Insulin Secretion

Hindrik Mulder1, Shumin Yang1, Maria Sörhede Winzell1, Cecilia Holm1, and Bo Ahrén2

1 Department of Cell and Molecular Biology, Lund University, Lund, Sweden
2 Department of Medicine, Lund University, Lund, Sweden

Lipids may serve as coupling factors in KATP-independent glucose sensing in ß-cells. We have previously demonstrated that ß-cells harbor lipase activities, one of which is the hormone-sensitive lipase. Whether ß-cell lipases are critical for glucose-stimulated insulin secretion (GSIS) by providing lipid-derived signals from endogenous lipids is unknown. Therefore, using a lipase inhibitor (orlistat), we examined whether lipase inhibition reduces insulin secretion. Islet lipolysis stimulated by glucose and diglyceride lipase activity was abolished by orlistat. Incubation of rat islets with orlistat dose dependently inhibited GSIS; this inhibition was reversed by 1 mmol/l palmitate, suggesting that orlistat acts via impaired formation of an acylglyceride-derived coupling signal. Orlistat inhibited the potentiating effect of forskolin on GSIS, an effect proposed to be due to activation of a lipase. In perifused islets, orlistat attenuated mainly the second phase of insulin secretion. Because the rise in islet ATP/ADP levels in response to glucose and oxidation of the sugar were unaffected by orlistat whereas the second phase of insulin secretion was reduced, it seems likely that a lipid coupling factor involved in KATP-independent glucose sensing has been perturbed. Thus, ß-cell lipase activity is involved in GSIS, emphasizing the important role of ß-cell lipid metabolism for insulin secretion.


Address correspondence and reprint requests to Hindrik Mulder, MD, PhD, Section for Molecular Signaling, Department of Cell and Molecular Biology, Lund University, BMC C11 SE-221 84 Lund, Sweden. E-mail: hindrik.mulder{at}medkem.lu.se


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. L. Hurley, L. K. Barre, S. D. Wood, K. A. Anderson, B. E. Kemp, A. R. Means, and L. A. Witters
Regulation of AMP-activated Protein Kinase by Multisite Phosphorylation in Response to Agents That Elevate Cellular cAMP
J. Biol. Chem., December 1, 2006; 281(48): 36662 - 36672.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. J. Nolan, M. S.R. Madiraju, V. Delghingaro-Augusto, M.-L. Peyot, and M. Prentki
Fatty Acid Signaling in the {beta}-Cell and Insulin Secretion
Diabetes, December 1, 2006; 55(Supplement_2): S16 - S23.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Fex, S. Lucas, M. S. Winzell, B. Ahren, C. Holm, and H. Mulder
{beta}-Cell Lipases and Insulin Secretion
Diabetes, December 1, 2006; 55(Supplement_2): S24 - S31.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. H. Claus, D. B. Lowe, Y. Liang, A. I. Salhanick, C. K. Lubeski, L. Yang, L. Lemoine, J. Zhu, and K. B. Clairmont
Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Hu, J. T. Deeney, C. J. Nolan, M.-L. Peyot, A. Ao, A. M. Richard, E. Luc, N. J. Faergeman, J. Knudsen, W. Guo, et al.
Regulation of lipolytic activity by long-chain acyl-coenzyme A in islets and adipocytes
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1085 - E1092.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
P. Thams, M. R Anwar, and K. Capito
Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway
Eur. J. Endocrinol., April 1, 2005; 152(4): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Pappan, Z. Pan, G. Kwon, C. A. Marshall, T. Coleman, I. J. Goldberg, M. L. McDaniel, and C. F. Semenkovich
Pancreatic {beta}-Cell Lipoprotein Lipase Independently Regulates Islet Glucose Metabolism and Normal Insulin Secretion
J. Biol. Chem., March 11, 2005; 280(10): 9023 - 9029.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Fex, C. S. Olofsson, U. Fransson, K. Bacos, H. Lindvall, M. Sorhede-Winzell, P. Rorsman, C. Holm, and H. Mulder
Hormone-Sensitive Lipase Deficiency in Mouse Islets Abolishes Neutral Cholesterol Ester Hydrolase Activity but Leaves Lipolysis, Acylglycerides, Fat Oxidation, and Insulin Secretion Intact
Endocrinology, August 1, 2004; 145(8): 3746 - 3753.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M.-L. Peyot, C. J. Nolan, K. Soni, E. Joly, R. Lussier, B. E. Corkey, S. P. Wang, G. A. Mitchell, and M. Prentki
Hormone-Sensitive Lipase Has a Role in Lipid Signaling for Insulin Secretion but Is Nonessential for the Incretin Action of Glucagon-Like Peptide 1
Diabetes, July 1, 2004; 53(7): 1733 - 1742.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.